Laying the foundations for a GenAI future: Roche’s journey
At Breakthrough 2025, Roche’s Jorge Carmona Toscano will join a panel discussion on emerging IT strategies to maximize the value of data and bed in greater GenAI use.
Mariette Boerstoel Streefland
SVP, Worldwide Patient Safety Office – Bristol Myers Squibb
Felix Arellano
Global Head of Drug Safety – Roche
Hans van Leeuwen
Global Head of Regulatory Operations – Astellas
Julie Thomas
Vice President, Global Medical Safety Operations – J & J
At Breakthrough 2025, Roche’s Jorge Carmona Toscano will join a panel discussion on emerging IT strategies to maximize the value of data and bed in greater GenAI use.
At Breakthrough 2025, Hans van Leeuwen, Global Head of Regulatory Affairs Data & Systems at Astellas Pharma, will take part in a panel discussion on the pursuit of greater interoperability between Regulatory and Safety systems.
Are you eager to attend Breakthrough 2025 this March in Zurich but need to secure approval from your manager or team?
In anticipation of a rousing Breakthrough 2025, Regulatory consultant and panel session moderator Preeya Beczek sets out her hopes for this year’s event.
Steve Gens previews some of the new research findings he’ll come armed with to a discussion panel on the future of Regulatory operations in an AI automation context.
Breakthrough 2025 is set to be a pivotal event for safety, regulatory, and life sciences professionals.
In the rapidly evolving landscape of regulatory affairs, significant advancements and trends are shaping the future. At ArisGlobal, we're committed to staying at the forefront of these changes and ensuring our clients are well-prepared. Here's a deep dive into the latest developments and what to expect in the coming years.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved